PKD Clinic Named a Center of Excellence

The PKD (polycystic kidney disease) Foundation has named The University of Kansas Health System’s PKD clinic as a Center of Excellence. The foundation’s Centers of Excellence (COE) program was launched and accepted its first clinic applicants in 2022. Its inaugural list of 28 Centers of Excellence, which includes our clinic, was announced recently.

The PKD Foundation developed the COE program to recognize PKD clinics that offer patient-focused, comprehensive care that include the support of an integrated, multidisciplinary care team. Goals of the program are to better understand PKD through research, ensure better care for people with PKD, and to educate and empower those who have PKD.

At The University of Kansas Health System, we are committed to providing extraordinary, compassionate care for polycystic kidney disease. We are 1 of only 4 National Institutes of Health-designated PKD research and translation core centers, and our PKD physicians offer the most advanced diagnosis and treatment options in the world, including access to the latest clinical trials and treatments.

Our PKD care team provides:

• A multidisciplinary approach to care, including shared care with primary care physicians
• A nationally recognized, complete continuum of kidney care, including dialysis and transplant, and use of the only FDA-approved medication to treat PKD, tolvaptan
• Board-certified specialists with PKD experience
• One of the nation’s top kidney research facilities, the Kidney Institute at the University of Kansas Medical Center